Abstract
What is this summary about?This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol-budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Administration, Inhalation
-
Adolescent
-
Adult
-
Aged
-
Albuterol* / administration & dosage
-
Anti-Asthmatic Agents / administration & dosage
-
Asthma* / drug therapy
-
Bronchodilator Agents* / administration & dosage
-
Budesonide* / administration & dosage
-
Drug Combinations*
-
Female
-
Humans
-
Male
-
Middle Aged
-
Nebulizers and Vaporizers*
-
Treatment Outcome
-
Young Adult
Substances
-
Albuterol
-
Drug Combinations
-
Bronchodilator Agents
-
Budesonide
-
Anti-Asthmatic Agents